Jazz Pharmaceuticals
JAZZ
JAZZ
447 hedge funds and large institutions have $7.76B invested in Jazz Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 89 funds opening new positions, 164 increasing their positions, 132 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 406 → 447 (+41)
1.61% more ownership
Funds ownership: 90.35% → 91.97% (+1.6%)
15% less call options, than puts
Call options by funds: $33.9M | Put options by funds: $40M
Holders
447
Holding in Top 10
5
Calls
$33.9M
Puts
$40M
Top Buyers
| 1 | +$104M | |
| 2 | +$94.2M | |
| 3 | +$64.4M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$44.9M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$37.6M |
Top Sellers
| 1 | -$76.4M | |
| 2 | -$74.1M | |
| 3 | -$67.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$65.4M |
| 5 |
JP Morgan Chase
New York
|
-$38.1M |